 It may be reasonable to begin perioperative beta blockers in speciÔ¨Åc patient groups (see section
on the perioperative management of patients undergoing CEA).
Either single or dual antiplatelet therapy should be
continued in the perioperative period for CEA to
decrease the risk of both stroke and perioperative MI,
particularly in patients with known preexisting coronary
artery disease or prior percutaneous coronary procedures. The American College of Cardiology Perioperative
Guidelines endorses